Registration Opens for FDA’s 2024 Regulatory Education for Industry Annual Conference

Registration is open for the Food and Drug Administration’s Regulatory Education for Industry (REdI) Annual Conference, which will take place May 29-30 in a hybrid format. This complimentary conference allows attendees to learn from the FDA’s regulatory experts in medical product centers and provides participants with a foundation in FDA’s regulatory requirements.

The conference includes tracks for drugs, devices and biologics. The biologics track will focus on regulatory submissions for cellular and gene therapy products, patient engagement, licensure of blood establishments and post-marketing evaluation of biological products, among other topics.

The plenary session will focus on innovation in medical products, research, product design, data collection and analysis. This session will also provide a perspective of the current state of innovation at FDA, focusing on current and planned activities.